NCT06808685View on ClinicalTrials.gov

Real World Multicenter National Study to Evaluate the Effectiveness and Safety of Biosimilar Bevacizumab Elovie

Not yet recruitingOBSERVATIONAL
Enrollment

133

Participants

Timeline

Start Date

April 24, 2025

Primary Completion Date

April 24, 2027

Study Completion Date

April 30, 2027

Conditions
Metastatic Colorectal Cancer
All Listed Sponsors
lead

Libbs Farmacêutica LTDA

INDUSTRY